Cartesian Therapeutics CVR
13F holders, Q1 2026 (March 31)2holders −2
0new positions
2sold out
$0.03avg. 13F price*
At the end of Q1 2026, 2 institutions reported holding Cartesian Therapeutics CVR in their 13F filings, down 2 from Q4 2025. 0 opened new positions and 2 sold out. The largest holders were Sterling Capital Management LLC ($6K) and Ironwood Investment Management LLC ($0).
- Company
- Cartesian Therapeutics CVR
- CUSIP
- 816212112
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $0 |
All 13F filers, Q4 2025 → Q1 2026: 1,188 shares sold, net −1,188 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Sterling Capital Management LLC | 0.00% | No change | 8,268 | $6K |
| Ironwood Investment Management LLC | 0.00% | No change | 170,087 | $0 |
"% of holder's portfolio" is Cartesian Therapeutics CVR's weight in each manager's 13F, not the share of Cartesian Therapeutics CVR the manager owns.